Literature DB >> 8411527

Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990.

C L Pashos1, J P Newhouse, B J McNeil.   

Abstract

OBJECTIVE: To investigate changes between 1987 and 1990 in the care and outcomes associated with acute myocardial infarction (AMI) in elderly patients.
DESIGN: Retrospective cohort study using a longitudinal database created from Medicare administrative files. PATIENTS: Cohorts comprising a total of 856,847 AMI patients insured by Medicare between 1987 and 1990. MAIN OUTCOME MEASURES: Annual rates of mortality at 30 days and 1 year following AMI, and the use of coronary angiography, coronary artery bypass graft surgery, and percutaneous transluminal coronary angioplasty during the first 90 days after a new AMI.
RESULTS: Between 1987 and 1990, mortality rates decreased 10% overall from 26% to 23% at 30 days (P < .001) and from 40% to 36% at 1 year following AMI (P < .001). Declines in mortality and adjusted risks of 1-year mortality were similar in men and women and in blacks and whites, but mortality declines were more evident in those younger than 85 years. Meanwhile, the proportion of elderly AMI patients having angiography within the first 90 days after their index admission increased from 24% to 33% (P < .001); proportions increased for both genders and all races. The proportion of patients undergoing revascularization procedures increased from 13% to 21%; while rates of bypass surgery increased from 8% to 11%, rates of angioplasty doubled from 5% to 10% (all P < .001).
CONCLUSIONS: Between 1987 and 1990, survival of elderly patients following AMI improved significantly. While changes in patient treatment may be responsible, the increased use of thrombolytic therapy appears to be only a partial explanation. Also, while the use of coronary angiography and revascularization procedures increased dramatically, the degree to which it caused the improvement in survival could not be determined.

Entities:  

Mesh:

Year:  1993        PMID: 8411527

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

1.  Underuse of invasive procedures among Medicaid patients with acute myocardial infarction.

Authors:  E F Philbin; P A McCullough; T G DiSalvo; G W Dec; P L Jenkins; W D Weaver
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

2.  Acute myocardial infarction without thrombolytic therapy: beneficial effects of magnesium sulfate.

Authors:  M Shechter; H Hod; P Chouraqui; E Kaplinsky; B Rabinowitz
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 3.  Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use.

Authors:  E M Antman; M S Seelig; K Fleischmann; J Lau; K Kuntz; C S Berkey; M W McIntosh
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

Review 4.  Risk assessment after myocardial infarction: have the rules changed with thrombolytic therapy?.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

Review 5.  Defining outcomes in older patients with cardiovascular disease.

Authors:  C L Pashos
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

6.  Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.

Authors:  P A Rochon; G M Anderson; J V Tu; J P Clark; J H Gurwitz; J P Szalai; P Lau
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

7.  Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996.

Authors:  J V Tu; C D Naylor; P Austin
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

8.  Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.

Authors:  D McCormick; J H Gurwitz; J Savageau; J Yarzebski; J M Gore; R J Goldberg
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

9.  Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction.

Authors:  Adrian Chrastina; Peter Pokreisz; Jan E Schnitzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

10.  Market reform in New Jersey and the effect on mortality from acute myocardial infarction.

Authors:  Kevin G M Volpp; Sankey V Williams; Joel Waldfogel; Jeffrey H Silber; J Sanford Schwartz; Mark V Pauly
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.